Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Arthritis 2020-Aug

Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
リンクがクリップボードに保存されます
Augusta Ortolan
Mariagrazia Lorenzin
Mara Felicetti
Roberta Ramonda

キーワード

概要

Objective: the aim of our systematic review and meta-analysis was to investigate whether overweight/obesity are associated with higher disease activity measures in axial spondyloarthritis (axSpA) patients.

Methods: MEDLINE, PubMed and Web of Science were searched using key terms corresponding to population (axSpA), exposure (overweight/obesity) and outcome (Bath Ankylosing Spondylitis Disease Activity Index, BASDAI; Ankylosing spondylitis disease activity score, ASDAS). Predefined inclusion criteria were: 1) adult axSpA patients 2) exposure classified according to Body Mass Index-BMI-; 3) BASDAI/ASDAS reported for each BMI group; 4) observational studies. Newcastle-Ottawa Scale for cohort, cross-sectional and case-control studies was used for quality check. Random-effects meta-analysis was used to pool results, which were expressed as mean difference (MD) in BASDAI and ASDAS between BMI groups, with 95% confidence intervals (95%CI).

Results: ten articles were included in the meta-analysis. The MD in BASDAI between normal BMI and overweight/obese patients was -0.38 (95%CI:-0.56,-0.21, p<0.0001); the MD in ASDAS between the same groups was -0.19 (95%CI:-0.29,-0.09, p<0.0001). The MD in BASDAI between normal BMI/overweight patients was -0.09 (95%CI:-0.33,0.15, p=0.45) and MD between normal BMI/obese patients was -0.78 (95%CI:-1.07,-0.48, p<0.0001). As for ASDAS, the MD between normal BMI/overweight patients was -0.02 (95%CI:-0.19,0.15, p=0.79) and MD between normal BMI/obese patients was (-0.42; 95%CI:-0.60,-0.23, p<0.0001).

Conclusions: overweight and obese axSpA patients tend to present higher disease activity scores compared to normal BMI patients. This difference seems to be clinically meaningful only for the comparison between obese and normal BMI patients, and more for BASDAI than ASDAS.

Keywords: Ankylosing Spondylitis Disease Activity Score (ASDAS); Bath Ankylosing Spondylitis Disease Activity Index (BASDAI); Body Mass Index (BMI); Spondyloarthritis; disease activity.

Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge